Tumor-draining lymph node-derived lymphocyte (LNL): clinical trials recruiting now
4
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 4
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Neoplasms · Tumor-draining lymph node-derived lymphocyte (LNL) for Breast Neoplasms | 4 |
| Breast cancer · Tumor-draining lymph node-derived lymphocyte (LNL) for Breast cancer | 4 |
Recruiting trials involving Tumor-draining lymph node-derived lymphocyte (LNL)
- Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
- Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
- Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
- Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Common questions
How many recruiting trials involve Tumor-draining lymph node-derived lymphocyte (LNL)?
4 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.